Austin, TX 3/8/12 (StreetBeat) –Flotek (NYSE: FTK) surges on earnings, revenuesThe drilling-equipment maker reported fourth-quarter profit of $0.20 a share on revenue of $74.9 million. Analysts had expected $0.15 and $73.8 million. The company is also growing quickly overseas, and FTK rallied 7 percent on tradeMONSTER's extended-hours platform.
Kratos Defense (Nasdaq: KTOS) Blows Past Estimates
Kratos Defense and Security reported profit of $0.17 a share, crushing the $0.01 analyst forecast. Revenue guidance was also strong looking forward, and KTOS rallied 16 percent before the bell.
AMAG (Nasdaq: AMAG) Rallies on Anemia-Drug Tests
The pharmaceuticals company has had disappointments before, but yesterday afternoon AMAG announced that its Feraheme anemia drug had met its primary endpoints. Overall adverse effects were also comparable with patients who had received IV iron sucrose. AMAG is popping 9 percent in extended trade.
Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.
StreetBeat Disclaimer
No comments:
Post a Comment